Imunon Inc (NAS:IMNN)
$ 0.7976 -0.0216 (-2.63%) Market Cap: 11.49 Mil Enterprise Value: 7.57 Mil PE Ratio: 0 PB Ratio: 2.00 GF Score: 38/100

Celsion Corp at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2021 / 08:30PM GMT
Release Date Price: $13.41 (-3.47%)
Daniil Gataulin
Chardan - Analyst

Hi, everyone, and thank you for joining us at Chardan's Fifth Annual Genetic Medicines Conference. My name is Daniil Gataulin; I am a Senior Biotech Associate at Chardan. It is my pleasure to introduce our next presenting guests from Celsion, Michael Tardugno, Chairman and CEO and Dr. Khursheed Anwer, Chief Scientific Officer. The format for this session is a fireside chat. I encourage the members of the audience to ask questions. (Conference Instructions). And with that, I can get right into it.

Questions & Answers

Daniil Gataulin
Chardan - Analyst

To begin, Michael, if you could give us a few minutes overview of Celsion and perhaps highlight recent accomplishments.

Michael Tardugno
Celsion Corporation - Chairman, President & CEO

Sure. Well, first, thank you for inviting us to the conference today. We are delighted to be here. Chardan always provides a terrific conference for both the presenters and the investment community.

Celsion is a clinical-stage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot